Windtree Therapeutics Inc
WINT
WINT was delisted on the 4th of May, 2017.
50 hedge funds and large institutions have $49.7M invested in Windtree Therapeutics Inc in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 16 closing their positions.
23% more capital invested
Capital invested by funds: $40.5M → $49.7M (+$9.24M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
22% less funds holding
Funds holding: 64 → 50 (-14)
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
47% less call options, than puts
Call options by funds: $113K | Put options by funds: $213K
81% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$866K |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$506K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$80.1K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$64.2K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$45.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$679K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$580K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$349K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$258K |
| 5 |
DM
Deerfield Management
New York
|
-$251K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Jane Street
New York
| – | -$120K | -5,634 | Closed |
|
|
CI
52
Cowen Inc
New York
| – | -$101K | -4,729 | Closed |
|
|
CS
53
Credit Suisse
Zurich,
Switzerland
| – | -$97K | -4,548 | Closed |
|
54
Barclays
London,
United Kingdom
| – | -$75K | -3,543 | Closed |
|
55
JP Morgan Chase
New York
| – | -$63K | -2,967 | Closed |
|
56
ProShare Advisors
Bethesda,
Maryland
| – | -$53K | -2,477 | Closed |
|
|
NFA
57
Nationwide Fund Advisors
Columbus,
Ohio
| – | -$33K | -1,535 | Closed |
|
58
Renaissance Technologies
New York
| – | -$19K | -885 | Closed |
|
|
CAS
59
CTC Alternative Strategies
Chicago,
Illinois
| – | -$18.2K | -857 | Closed |
|
|
APU
60
Alpine Partners USVI
St. Thomas,
U.S. Virgin Islands
| – | -$15K | -727 | Closed |
|
|
TCIM
61
TIAA CREF Investment Management
New York
| – | -$14K | -652 | Closed |
|
WINT Hedge Fund Activity: Q3 2013 in Review
50 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q3 2013, worth a combined $49.7M — up 23% from $40.5M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of WINT and 3 opened new positions — a net loss of 13 holders — while 21 trimmed existing stakes and 13 added.
The largest buyer was Broadfin Capital, adding an estimated $866K. The largest seller was Wells Fargo, cutting an estimated $679K.
- 50 institutional investors held Windtree Therapeutics Inc (WINT) as of Q3 2013, down from 64 in Q2 2013.
- Funds reported $49.7M of Windtree Therapeutics Inc stock for Q3 2013, up 23% quarter-over-quarter.
- 3 funds opened new Windtree Therapeutics Inc positions in Q3 2013 and 16 closed out, a net change of -13 holders.
- The largest Windtree Therapeutics Inc buyer in Q3 2013 was Broadfin Capital, an estimated $866K added.
- The largest Windtree Therapeutics Inc seller in Q3 2013 was Wells Fargo, an estimated $679K sold.
Based on aggregated 13F filings for Q3 2013.